Medine.co.uk

Pantoprazole Distriquimica 20 Mg Gastro-Resistant Tablets

Informations for option: Pantoprazole Distriquimica 20 Mg Gastro-Resistant Tablets, show other option

Package leaflet: Information for the patient

Pantoprazole Distriquimica 20 mg gastro-resistant tablets

Pantoprazole

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

-    Keep this leaflet. You may need to read it again.

-    If you have any further questions, ask your doctor or pharmacist.

-    This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

-    If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet:

1.    What Pantoprazole Distriquimica 20 mg is and what it is used for

2.    What you need to know before you take Pantoprazole Distriquimica 20 mg

3.    How to take Pantoprazole Distriquimica 20 mg

4.    Possible side effects

5.    How to store Pantoprazole Distriquimica 20 mg

6.    Contents of the pack and other information

1.    What Pantoprazole Distriquimica 20 mg is and what it is used for

Pantoprazole Distriquimica 20 mg is a selective “proton pump inhibitor”, a medicine which reduces the amount of acid produced in your stomach. It is used for treating acid-related diseases of the stomach and intestine.

Pantoprazole Distriquimica 20 mg is used for:

Adults and adolescents 12 years of age and above:

-    Treating symptoms (e.g. heartburn, acid regurgitation, pain on swallowing) associated to gastro-oesophageal reflux disease caused by reflux of acid from the stomach.

-    Long-term management of reflux oesophagitis (inflammation of the oesophagus accompanied by the regurgitation of stomach acid) and preventing its return.

Adults:

-    Preventing duodenal and stomach ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs, for example, ibuprofen) in patients at risk who need to take NSAIDs continuously.

2.    What you need to know before you take Pantoprazole Distriquimica 20 mg Do not take Pantoprazole Distriquimica 20 mg:

-    If you are allergic to pantoprazole or any of the other ingredients of this medicine (listed in section 6).

-    If you are allergic to medicines containing other proton pump inhibitors.

Warnings and precautions

-    If you have severe liver problems. Please tell your doctor if you have ever had problems with your liver. He will check your liver enzymes more frequently, especially when you are taking Pantoprazole Distriquimica 20 mg as a long-term treatment. In the case of a rise of liver enzymes the treatment should be stopped.

-    If you need to take medicines called NSAIDs continuously and receive Pantoprazole

Distriquimica 20 mg because you have an increased risk of developing stomach and intestinal complications. Any increased risk will be assessed according to your own personal risk factors such as your age (65 years old or more), a history of stomach or duodenal ulcers or of stomach or intestinal bleeding.

-    If you have reduced body stores or risk factors for reduced vitamin B12 and receive pantoprazole long-term treatment. As with all acid reducing agents, pantoprazole may lead to a reduced absorption of vitamin B12.

-    If you are taking a medicine containing atazanavir (for the treatment of HIV-infection) at the same time as pantoprazole, ask your doctor for specific advise.

-    If you have ever had a skin reaction after treatment with a medicine similar to Pantoprazole Distriquimica 20 mg that reduces stomach acid.

If you get a rash on your skin, especially in areas exposed to the sun tell your doctor as soon as you can, as you may need to stop your treatment with Pantoprazole Distriquimica 20 mg. Remember to also mention any other ill-effects like pain in your joints.

Tell your doctor immediately if you notice any of the following symptoms:

-    an unintentional loss of weight

-    repeated vomiting

-    difficulty in swallowing

-    vomiting blood

-    you look pale and feel weak (anaemia)

-    you notice blood in your stools

-    severe and/or persistent diarrhoea, as Pantoprazole Distriquimica 20 mg has been associated with a small increase in infectious diarrhoea.

Your doctor may decide that you need some tests to rule out malignant disease because pantoprazole also alleviates the symptoms of cancer and could cause delay in diagnosing it. If your symptoms continue in spite of your treatment, further investigations will be considered.

Taking a proton pump inhibitor like Pantoprazole Distriquimica 20 mg, especially over a period of more than one year, may slightly increase your risk of fracture in the hip, wrist or spine. Tell your doctor if you have osteoporosis or if you are taking corticosteroids (which can increase the risk of osteoporosis).

If you take Pantoprazole Distriquimica 20 mg on a long-term basis (longer than 1 year) your doctor will probably keep you under regular surveillance. You should report any new and exceptional symptoms and circumstances whenever you see your doctor.

Other medicines and Pantoprazole Distriquimica 20 mg

Pantoprazole Distriquimica 20 mg may influence the effectiveness of other medicines, so tell your doctor if you are taking

-    Medicines such as ketoconazole, itraconazole and posaconazole (used to treat fungal infections) or erlotinib (used for certain types of cancer) because Pantoprazole Distriquimica 20 mg may stop these and other medicines from working properly.

-    Warfarin and phenprocoumon, which affect the thickening, or thinning of the blood. You may need further checks.

-    Atazanavir (used to treat HIV -infection).

-    Methotrexate (a chemotherapy medicine used in high doses to treat cancer) - if you are taking a high dose of methotrexate, your doctor may temporarily stop your treatment with Pantoprazole Distriquimica 20 mg.

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Pregnancy and breast-feeding

There are no adequate data from the use of pantoprazole in pregnant women. Excretion into human milk has been reported.

If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor of pharmacist for advice before taking this medicine.

Driving and using machines

If you experience side effects like dizziness or disturbed vision, you should not drive or operate machines.

Pantoprazole Distriquimica 20 mg contains lactose and sodium.

This medicine contains lactose. Please only take Pantoprazole Distriquimica 20 mg after you have consulted your doctor, if you know that you suffer from tolerance problems with certain sugars.

This medicinal product contains 1.34 mg sodium per dose. This should be taken into consideration by patients on a controlled sodium diet.

3. How to take Pantoprazole Distriquimica 20 mg

Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

Take the tablets 1 hour before a meal without chewing or breaking them and swallow them whole with some water.

Unless told otherwise by your doctor, the recommended dose is:

Adults and adolescents 12 years of age and above:

To treat symptoms (e.g. heartburn, acid regurgitation, pain on swallowing) associated to gastro-oesophageal reflux disease

The usual dose is one tablet a day. This dose usually brings relief within 2 - 4 weeks - at most after another 4 weeks. Your doctor will tell you how long to continue taking the medicine. After this any recurring symptoms can be controlled by taking one tablet daily, when required.

For long-term management and for preventing the return of reflux oesophagitis

The usual dose is one tablet a day. If the illness returns, your doctor can double the dose, in which case you can use Pantoprazole Distriquimica 40 mg tablets instead, one a day. After healing, you can reduce the dose back again to one tablet 20 mg a day.

Adults:

To prevent duodenal and stomach ulcers in patients who need to take NSAIDs continuously

The usual dose is one tablet a day.

Special patient groups:

If you suffer from severe liver problems, you should not take more than one 20 mg tablet a day.

Use in children below 12years:

These tablets are not recommended for use in children below 12 years.

If you take more Pantoprazole Distriquimica 20 mg than you should

Tell your doctor or pharmacist. There are no known symptoms of overdose.

If you forget to take Pantoprazole Distriquimica 20 mg

Do not take a double dose to make up for a forgotten dose. Take your next normal dose at the usual time.

If you stop taking Pantoprazole Distriquimica 20 mg

Do not stop taking these tablets without first talking to your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The frequency of possible side effects listed below is defined using the following convention:

very common (affects more than 1 user in 10)

common (affects 1 to 10 users in 100)

uncommon (affects 1 to 10 users in 1,000)

rare (affects 1 to 10 users in 10,000)

very rare (affects less than 1 user in 10,000)

not known (frequency cannot be estimated from the available data)

If you get any of the following side effects, stop taking these tablets and tell your doctor immediately, or contact the casualty department at your nearest hospital:

-    Serious allergic reactions (frequency rare): swelling of the tongue and/or throat, difficulty in swallowing, hives (nettle rash), difficulties in breathing, allergic facial swelling (Quincke’s oedema/angioedema), severe dizziness with very fast heartbeat and heavy sweating.

-    Serious skin conditions (frequency not known): blistering of the skin and rapid deterioration of your general condition, erosion (including slight bleeding) of eyes, nose, mouth/lips or genitals (Stevens-Johnson-Syndrome, Lyell-Syndrome, Erythema multiforme) and sensitivity to light.

-    Other serious conditions (frequency not known): yellowing of the skin or whites of the eyes (severe damage to liver cells, jaundice) or fever, rash, and enlarged kidneys sometimes with painful urination and lower back pain (serious inflammation of the kidneys).

Other side effects are:

-    Uncommon (affects 1 to 10 users in 1,000)

headache; dizziness; diarrhoea; feeling sick, vomiting; bloating and flatulence (wind); constipation; dry mouth; abdominal pain and discomfort; skin rash, exanthema, eruption; itching; feeling weak, exhausted or generally unwell; sleep disorders; fracture of the hip, wrist or spine (if pantoprazole is used in high doses and over a long period of time)..

-    Rare (affects 1 to 10 users in 10,000)

disturbances in vision such as blurred vision; hives; pain in the joints; muscle pains; weight changes; raised body temperature; swelling of the extremities (peripheral oedema); allergic reactions; depression; breast enlargement in males; distortion or complete lack of the sense of taste.

-    Very Rare (affects less than 1 user in 10,000) disorientation.

-    Not known (frequency cannot be estimated from the available data)

Hallucination, confusion (especially in patients with a history of these symptoms); decreased sodium level in blood; tingling feelings such as ‘pin and needles’; muscle spasm.

Side effects identified through blood tests:

-    Uncommon (affects 1 to 10 users in 1,000) an increase in liver enzymes.

-    Rare (affects 1 to 10 users in 10,000)

an increase in bilirubin; increased fats in the blood; severe reduction in the number of white blood cells (agranulocytosis), which may lead to more frequent infections.

-    Very Rare (affects less than 1 user in 10,000)

a reduction in the number of blood platelets, which may cause you to bleed or bruise more than

normal; a reduction in the number of white blood cells (leucopenia), which may lead to more frequent infections; coexisting abnormal reduction in the number of both, red and white blood cells (pancytopenia).

- Not known (frequency cannot be estimated from the available data) rash, possibly with pain in the joints.

If you are on Pantoprazole Distriquimica 20mg for more than three months it is possible that the levels of magnesium in your blood may fall. Low levels of magnesium can be seen as fatigue, involuntary muscle contractions, disorientation, convulsions, dizziness, increased heart rate. If you get any of these symptoms, please tell your doctor promptly. Low levels of magnesium can also lead to a reduction in potassium or calcium levels in the blood. Your doctor may decide to perform regular blood tests to monitor your levels of magnesium.

Reporting of side effects

If you get any side effects, talk to your doctor of pharmacist. This includes any possible side effects not

listed in this leaflet. You can also report side effects directly via Yellow Card Scheme. By reporting

side effects you can help provide more information on the safety of this medicine.

Website: www.mhra.gov.uk/yellowcard

5. How to store Pantoprazole Distriquimica 20 mg

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and the container after EXP.

The expiry date refers to the last day of that month.

Tablet container: Shelf life after first opening: 90 days.

Storage conditions:

Tablet container: Do not store above 25 °C.

Blister: Do not store above 30 °C.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to

throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information What Pantoprazole Distriquimica 20 mg contains

-    The active substance is pantoprazole. Each gastro-resistant tablet contains 20 mg of pantoprazole (as sodium sesquihydrate).

-    The other ingredients are:

Tablet Core:

microcrystalline cellulose (E460i), lactose monohydrate, croscarmellose sodium, colloidal anhydrous silica, magnesium stearate

Colour coating:

polyvinyl alcohol, macrogol 3350, titanium dioxide (E171), talc (E553b), iron oxide yellow (E172), quinoline yellow aluminium lake (E104)

Gastro-resistant coating:

methacryl acid-ethyl acrylate copolymer, sodium lauryl sulphate, polysorbate 80, triethyl citrate (E1505), talc (E553b)

What Pantoprazole Distriquimica 20 mg looks like and contents of the pack

Pantoprazole Distriquimica 20 mg are yellow to ochre, elongated coated tablets.

Pantoprazole Distriquimica 20 mg is available in:

Tablet containers (HDPE bottles with HDPE or PP screw cap closure with desiccant) in packages of 7, 14, 28, 30, 50 or 90 gastro-resistant tablets.

Blisters (Aluminium-Aluminium foil blisters) in packages of 7, 14, 28, 30, 56, 90 or 98 gastro-resistant tablets.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder:

To be completed nationally

Manufacturer:

Laboratorios Dr. Esteve S. A.

Sant Marti, s/n. Poligon Industrial 08107 Martorelles (Barcelona) Spain

This medicine is

Austria

Belgium

Denmark

Finland

Norway

Poland

The Netherlands United Kingdom


authorised in the Member States of the EEA under the following names: Pantoprazol A-med 20 mg magensaftresistente

Pantoprazole Distriquimica 20 mg maagsapresistente tablet/Comprime gastro-resistant/magensaftresistente Tablette Pantoprazole Pensa 20 mg Enterotabletter

Pantoprazole Pensa 20 mg Enterotabletti

Pantoprazole Pensa 20 mg Enterotabletter

Pantoprazole Distriquimica 20 mg Tabletki dojelitowe

Pantoprazole Pensa 20 mg, maagsapresistente tabletten

Pantoprazole Distriquimica 20 mg gastro-resistant tablets

This leaflet was last revised in January 2016.